|
|
Volumn 28, Issue 10, 2005, Pages 499-502
|
|
Second-line chemotherapy of advanced disseminated gastric cancer after cisplatin, infusional 5-fluorouracil, folinic acid (PLF): Benefit dependant on progression-free interval after first-line therapy
a a a a |
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CISPLATIN;
FLUOROURACIL;
FOLINIC ACID;
ARTICLE;
CANCER CHEMOTHERAPY;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CONFIDENCE INTERVAL;
DISSEMINATED CANCER;
HUMAN;
PREDICTION;
STATISTICAL SIGNIFICANCE;
STOMACH CANCER;
ADENOCARCINOMA;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CISPLATIN;
DISEASE-FREE SURVIVAL;
FEMALE;
FLUOROURACIL;
GERMANY;
HUMANS;
INFUSIONS, PARENTERAL;
LEUCOVORIN;
MALE;
MIDDLE AGED;
PROGNOSIS;
RETROSPECTIVE STUDIES;
RISK ASSESSMENT;
RISK FACTORS;
SALVAGE THERAPY;
STOMACH NEOPLASMS;
SURVIVAL RATE;
TREATMENT FAILURE;
TREATMENT OUTCOME;
|
|
EID: 26444529508
PISSN: 0378584X
EISSN: None
Source Type: Journal
DOI: 10.1159/000087136 Document Type: Article |
|
Times cited : (18)
|
|
References (0)
|